Hexcel Corp. (NYSE:HXL) ended the last trading day at $41.90. Company weekly volatility is calculated as 3.45% and price to cash ratio as 75.46. Hexcel Corp. (NYSE:HXL) showed a weekly performance of 4.99%.
Hexcel Corp. (NYSE:HXL) had its target price decreased by RBC Capital from $56.00 to $51.00 in a research note released on Monday, Marketbeat reports. RBC Capital currently has an outperform rating on the stock.
On 18 February, ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) shares moved down -6.79% and was closed at $19.22. ACAD EPS growth in last 5 year was 4.60%. ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) year to date (YTD) performance is -46.09%.
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) announced that the Psychopharmacologic Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) will review data included in ACADIA’s New Drug Application (NDA) for NUPLAZID™ (pimavanserin) for the treatment of psychosis associated with Parkinson’s disease. The Advisory Committee Meeting is scheduled for March 29, 2016.
The Dow Chemical Company (NYSE:DOW) shares moved down -0.88% in last trading session and ended the day at $47.57. DOW Gross Margin is 22.40% and its has a return on assets of 10.60%. The Dow Chemical Company (NYSE:DOW) quarterly performance is -7.08%.
On 12 February, The Dow Chemical Company (NYSE:DOW), Midland, Mich., expects to contribute approximately $620 million to its U.S. defined benefit plans in 2016, the company said in its latest 10-K form filed with the Securities and Exchange Commission on Friday.
Advanced Micro Devices, Inc. (NASDAQ:AMD) caters to the Technology space. It has a net profit margin of -16.50% and weekly performance is 3.80%. On the last day of trading company shares ended up at $1.91. Advanced Micro Devices, Inc. (NASDAQ:AMD) distance from 50-day simple moving average (SMA50) is -3.20%.
On 12 February, Advanced Micro Devices, Inc. (NASDAQ:AMD) is pinning a great deal on its Zen processors due out this year, but fortunately the more we hear about them, the more promising their overall chances seem.
Chemed Corp. (NYSE:CHE) caters to the Healthcare space. It has a net profit margin of 7.20% and weekly performance is -3.34%. On the last day of trading company shares ended up at $126.48. Chemed Corp. (NYSE:CHE) distance from 50-day simple moving average (SMA50) is -12.02%.
Chemed Corp. (NYSE:CHE) announced that it will deliver a presentation at the RBC Capital Markets’ Global Healthcare Conference on Wednesday, February 24, 2016, at approximately 9:00 a.m. (ET) at The New York Palace Hotel in New York City.